Peptonic Medical Receives Additional Order from US Partner
Peptonic Medical AB has received a new order from its US-based partner in women's intimate health, extending their existing agreement. The order covers North American markets and the United Kingdom.
Swedish company Peptonic Medical AB has secured a new order from an established US partner specializing in women's intimate self-care products for menopause and post-menopause stages. The agreement initially covered the United States, Canada, Mexico, and the United Kingdom.
Under the terms of the partnership, Peptonic will supply products that will be marketed and sold under the partner's own established brand as white-label goods. This latest order follows an initial order valued at approximately USD 120,000 received by Peptonic in October 2025.
The company views this subsequent order as a positive development and a validation of the product's market potential within the growing women's health sector. While the specific value of the new order has not been disclosed, it signifies a deepening of the collaboration between Peptonic and its US partner.